<DOC>
	<DOCNO>NCT01796626</DOCNO>
	<brief_summary>At least thirty ( 30 ) subject , Fitzpatrick-Goldman Skin Type I-IV enrol 2 clinical site ; clinic enroll least 15 subject . Subjects present visible wrinkle and/or striae require treatment . Hypothesis : The M22 ResurFX 1565nm module improve appearance wrinkle least 2 grade Fitzpatrick-Goldman Wrinkle Elastosis Score , striae least 50 % use VAS compare baseline , least 75 % subject .</brief_summary>
	<brief_title>Clinical Evaluation M22 ResurFX 1565nm Module</brief_title>
	<detailed_description />
	<criteria>Able read , understand provide write Informed Consent ; Healthy adult , male female , 2555 year age FitzpatrickGoldman skin type IIV ; Having suitable area treatment facial area treat wrinkle FitzpatrickGoldman Wrinkle Elastosis Score 36 stria alba present 1 year ; Able willing comply treatment/followup schedule requirement ; Women childbearing age require use reliable method birth control least 3 month prior enrollment throughout course study . Any following exclude subject study : skin type VVI 1 . Pregnant , intend become pregnant course study , less 3 month postpartum less 6 week completion breastfeeding ; 2 . History post inflammatory hyperpigmentation 3 . Unable unlikely refrain tanning , include use tan booth , course study ; 4 . Use photosensitive medication light exposure contraindicate . 5 . Use oral isotretinoin ( AccutaneÂ® ) within 6 month initial treatment course study . Note : skin must regain normal degree moisture prior treatment ; 6 . Prior treatment , chemical peel ( especially phenol base ) dermabrasion , treat area within 3 month initial treatment course study ; 7 . Prior skin treatment nonablative laser device treat area within 6 month initial treatment course study ; 8 . Prior use collagen , fat injection method skin augmentation ( enhancement inject implanted material ) treat area within 12 month initial treatment course study . Treatment may perform permanent dermal implant ; 9 . Prior use Botox treatment area within 6 month ; 10 . Prior ablative resurfacing procedure face lift treat area laser device within 12 month initial treatment course study ; 11 . Any surgery treat area within 9 month initial treatment course study ; 12 . History keloid type hypertrophic scar formation poor wound heal previously injure skin area ; 13 . Showing symptoms hormonal disorder , per Investigator 's discretion ( Melasma , Chloasma ) ; 14 . Concurrent inflammatory skin condition , include , limited , rosacea severity ; 15 . Open laceration abrasion sort area treat course treatment ; 16 . Active Herpes Simplex time treatment experience three episode Herpes Simplex eruption within year study enrollment ; 17 . Multiple dysplastic nevi area treat ; 18 . Having bleed disorder take anticoagulation medication , include heavy use aspirin , manner allow minimum 10 day washout period prior treatment ( per patient 's physician discretion ) ; 19 . History immunosuppression/immune deficiency disorder ( include HIV infection AIDS ) use immunosuppressive medication ; 20 . Having form active cancer time enrollment course study history skin cancer ; 21 . Significant concurrent illness , uncontrolled diabetes i.e . disease state opinion Investigator would interfere anesthesia , treatment , heal process ; Participation study another device drug within 3 month prior study enrollment study , per Investigator 's discretion , long contradictory criterion ; 22 . Mentally incompetent , prisoner evidence active substance alcohol abuse ; 23 . Any condition , Investigator 's opinion , would make unsafe ( subject study personnel ) treat subject part research study .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>